
PranaQ is a digital healthcare company based in New York City, specializing in wearable medical devices for sleep and breathing disorders. Leveraging AI-based biomedical signal processing algorithms, their flagship product, TipTraQ, offers FDA-cleared, accurate, and simple home sleep apnea diagnostics and monitoring. TipTraQ eliminates the need for cumbersome accessories like belts or cannulas, offering a hassle-free experience for patients. The system is entirely cloud-based, enabling automated data upload, instant results, and remote patient management, which helps clinicians expand their HSAT services, reduce testing backlogs, and grow their telehealth practices. The company has been validated by studies at Duke University Hospital and the University of California, San Francisco, and has received FDA 510(k) clearance. PranaQ's mission is to make healthcare more accessible and personalized through patient-centric home health solutions.

PranaQ is a digital healthcare company based in New York City, specializing in wearable medical devices for sleep and breathing disorders. Leveraging AI-based biomedical signal processing algorithms, their flagship product, TipTraQ, offers FDA-cleared, accurate, and simple home sleep apnea diagnostics and monitoring. TipTraQ eliminates the need for cumbersome accessories like belts or cannulas, offering a hassle-free experience for patients. The system is entirely cloud-based, enabling automated data upload, instant results, and remote patient management, which helps clinicians expand their HSAT services, reduce testing backlogs, and grow their telehealth practices. The company has been validated by studies at Duke University Hospital and the University of California, San Francisco, and has received FDA 510(k) clearance. PranaQ's mission is to make healthcare more accessible and personalized through patient-centric home health solutions.
Headquarters: New York, NY
Product: TipTraQ — single-point wearable for home sleep apnea testing
Regulatory: FDA 510(k) clearance for TipTraQ
Latest known funding: $3.0M seed (Dec 2022)
Home sleep apnea diagnostics and respiratory/sleep monitoring
2021
Digital health / Medical devices
$3,000,000
Company announcement (Dec 23, 2022) lists participation from DSC Investment, Smilegate Investment, NAVER D2SF, and Lighthouse Combined Investment.
“Seed investors include NAVER D2SF, DSC Investment, Smilegate Investment, Lighthouse Combined Investment”